Back to today’s briefing

Story perspectives

WeightWatchers Faces Bankruptcy Amid Weight-Loss Drug Surge

4/11/2025

33 7

Summary

Story summary

WeightWatchers (WW) faces bankruptcy with $1.6 billion in debt and decreasing revenue.
The popularity of GLP-1 weight-loss drugs, such as Ozempic, has diverted customers from traditional diets.
Subscriber count dropped from 5 million in 2021 to 3.3 million by late 2024.
Oprah Winfrey resigned from the board in 2024 after disclosing her use of weight-loss medication.
WW's future depends on negotiations with creditors in a shifting weight-loss market.

History

Historical Context

WeightWatchers' bankruptcy echoes the 1970s diet industry collapse, driven by fad diets and shifting consumer preferences. Just as the introduction of low-fat diets disrupted traditional weight-loss methods, today's GLP-1 drugs are reshaping the market, forcing companies like WW to adapt or face decline.

1 of 2

Story summary

WeightWatchers (WW) faces bankruptcy with $1.6 billion in debt and decreasing revenue.
The popularity of GLP-1 weight-loss drugs, such as Ozempic, has diverted customers from traditional diets.
Subscriber count dropped from 5 million in 2021 to 3.3 million by late 2024.
Oprah Winfrey resigned from the board in 2024 after disclosing her use of weight-loss medication.
WW's future depends on negotiations with creditors in a shifting weight-loss market.

1 / 2